Gordon, Nicole T.
Alberty-Oller, Jaime J.
Fei, Kezhen
Greco, Giampaolo
Gallagher, Emily J.
LeRoith, Derek
Feldman, Sheldon M.
Killilea, Bridgid
Boolbol, Susan K.
Choi, Lydia
Friedman, Neil
Pilewskie, Melissa
Port, Elisa
Tiersten, Amy
Bickell, Nina A.
Funding for this research was provided by:
National Cancer Institute (1R01CA171558-01)
Article History
Received: 31 May 2020
Accepted: 4 February 2021
First Online: 3 April 2021
Disclosures
: Emily Gallagher received research support from Alkeon Capital Management, and was a member of the Advisory Board for Novartis in 2019. Brigid Killelea received grant support from the sponsor (Mt. Sinai) for this study, and also received consulting fees from Genentech, which she believes is not relevant to this manuscript. Nicole T. Gordon, Jaime J. Alberty-Oller, Kezhen Fei, Giampaolo Greco, Derek LeRoith, Sheldon M. Feldman, Susan K. Boolbol, Lydia Choi, Neil Friedman, Melissa Pilewskie, Elisa Port, Amy Tiersten, and Nina A. Bickell have no disclosures to declare.